ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 694266 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 694266; 2) Community: the network communities that were significantly associated with the response to NSC 694266; 3) Molecule: the relationships between components within communities and NSC 694266; 4) MDR: the compounds that were significantly associated with the NSC 694266.

NSC Compound Enrichment Correlation
NSC 681633 Camptothecin Derivative 0.0385613993886001 0.31359844
NSC 682815 12H-7,11-Nitrilo-6H,20H-dibenzo[b,m][1,15,5,8,11] dioxatriazacyclodocosine, 21,22,23,24-tetrahydro- (9CI) 0.0385613993886001 0.096166622
NSC 683556 Camptothecin Derivative 0.0385613993886001 0.23839256
NSC 684043 1H-Imidazole-4-carboxamide, 5-[[(2-amino-2-carboxyethyl)thio]azo]- 0.0385613993886001 -0.16969391
NSC 685981 1,4-Butanediamine, N,N'-bis[(2-naphthalenyl)methyl- N,N'-bis[3-[(trifluoroacetyl)amino]propyl]- 0.0385613993886001 -0.17236253
NSC 693135 Null 0.0385613993886001 0.063857625
NSC 693576 Null 0.0385613993886001 0.2392115
NSC 694001 2-Butenedioic acid, (E)-, 2-[3-[[[4-(acetyloxy)butyl]- 1H-1,2,3-triazol-4-yl]methyl]-1,2,3,4-tetrahydro-5-methyl-2,4-dioxo-1-pyrimidinyl]-, diethyl ester 0.0385613993886001 -0.055519224
NSC 695586 Null 0.0385613993886001 0.538739
NSC 699145 Null 0.0385613993886001 0.14768691
Total:40  Current:25    [First] [Prev] [Next] [Last]